Crossmark

Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway

Crossref DOI link: https://doi.org/10.1038/s41375-018-0114-0

Published Online: 2018-03-28

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Busch, Leonhard

Mougiakakos, Dimitrios

Büttner-Herold, Maike

Müller, Miriam J.

Volmer, Dietrich A.

Bach, Christian

Fabri, Mario

Bittenbring, Jörg T.

Neumann, Frank

Boxhammer, Rainer

Nolting, Jens

Bisht, Savita

Böttcher, Martin

Jitschin, Simon

Hoffmann, Markus H.

Balzer, Heidi

Beier, Fabian

Gezer, Deniz

Dudziak, Diana

Gelse, Kolja

Hennig, Friedrich F.

Pallasch, Christian P.

Spriewald, Bernd

Mackensen, Andreas https://orcid.org/0000-0002-0685-4483
Bruns, Heiko
License Information

Text and Data Mining valid from 2018-03-28
More Information

Article History

Received: 21 November 2017

Revised: 15 February 2018

Accepted: 13 March 2018

First Online: 28 March 2018

Compliance with ethical standards

:

: RB is an employee of Morphosys. HB received research support from Celgene and Morphosys. The remaining authors declare that they have no conflict of interest.